MMitraTender

Ondansetron Tablet: GeM business opportunity

Who buys Ondansetron Tablet on GeM, in which states, how many sellers compete and what wins. Change the filters to match your business.

Live bids: 2Awarded results: 1Live tenders →

What can you do?

GeM categoryOndansetron Tablet
About your business

Live bids + bids closed 2025-11-07 – 2026-11-07 (365 days). Includes imported GeM history.

Live bids
2
Closed in period
15
Awarded results
1
Median winning price (L1)
₹91 lakh
Avg bidders per bid
3

Tenders published per month

Last 12 months, matching your filters

0 Dec 2025
0 Jan 2026
0 Feb 2026
1 Mar 2026
2 Apr 2026
2 May 2026
2 Jun 2026
1 Jul 2026
2 Aug 2026
44 Sept 2026
2 Oct 2026
1 Nov 2026
Show as table
MonthTenders
Dec 20250
Jan 20260
Feb 20260
Mar 20261
Apr 20262
May 20262
Jun 20262
Jul 20261
Aug 20262
Sept 20264
Oct 20262
Nov 20261

How open are these bids?

No EMD needed
57%

based on 7 bids

MSE turnover/experience relaxed
50%

based on 2 bids

Reverse auction
7%

based on 15 bids

Turnover, experience, EMD and exemptions come from bid documents and are still sparse; every share shows how many bids it is based on. Results improve as more history is imported.

Top 10: where to work

Ranked by opportunity score (0–100). Open a row to see why.

  1. 1
    Ondansetron Tablet73/100

    2 live · 3 bidders avg · L1 ₹91 lakh

    Live tenders →Create alert
    Why this score
    Volume
    100
    Momentum
    50
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  2. 2
    Metoprolol Tablet58/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    48
    Momentum
    94
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  3. 3
    Entecavir Tablet58/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    48
    Momentum
    94
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  4. 4
    Desvenlafaxine Tablets56/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    38
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  5. 5
    Lamivudine Tablet56/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    38
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  6. 6
    Bicalutamide Tablets (V2)56/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    38
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  7. 7
    Imatinib Tablet56/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    38
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  8. 8
    Sodium Hyaluronate Drops (V2)56/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    38
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  9. 9
    Letrozole Tablet55/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    67
    Momentum
    47
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  10. 10
    Flunarizine Tablet52/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    24
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
Show as table
RankNameScoreLive bidsClosed in periodAvg bidders per bidMedian winning price (L1)
1Ondansetron Tablet732153₹91 lakh
2Metoprolol Tablet5812——
3Entecavir Tablet5812——
4Desvenlafaxine Tablets5611——
5Lamivudine Tablet5611——
6Bicalutamide Tablets (V2)5611——
7Imatinib Tablet5611——
8Sodium Hyaluronate Drops (V2)5611——
9Letrozole Tablet5515——
10Flunarizine Tablet5210——
How the opportunity score works

Score = Volume 30% + Momentum 20% + Low competition 25% + Easy criteria 15% + Order value 10%. Each part is 0–100; a part without enough data counts as a neutral 50.

  • Volume: tenders in the period, compared with the biggest row of the list.
  • Momentum: share published in the last 30 days vs the average (100 = twice as fast).
  • Low competition: 2 bidders per bid = 100, 15 or more = 0.
  • Easy criteria: share of read bid documents with no EMD, an MSE/startup exemption or no turnover/experience criterion.
  • Order value: median winning (L1) price, compared with the highest in the list.

Who wins these bids

Top L1 sellers in awarded bids of the period

  1. 1 wins

1 different sellers won

Winner names are part of the ₹999 plan and the free trial.

See winner names
Bids won by MSE sellers100%

of 1 awarded bids with the MSE flag

AI business advisor

Get a short plan from these numbers: where to start, whom to sell to, what to prepare and the risks.

Ondansetron Tablet on GeM: Buyers, Competition & Winning Prices | Mitra Tender